In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.

Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death ...

ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...

Investigators conducted a retrospective analysis to determine whether postmenopausal women with a history of breast cancer can safely receive vaginal estrogen.

Investigators compared trial demographics against baseline electronic health record data at 3 NCI–designated cancer centers to identify enrollment gaps.

In this phase 3 trial, researchers aimed to characterize the clinical characteristics, treatment approaches, and outcomes of patients with metastatic non-rhabdomyosarcoma soft tissue sarcoma and to ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

Further, any overall survival (OS) benefit may not be specific to ICI therapy, according to study researchers with Memorial Sloan Kettering Cancer Center in New York. “Real-world data suggest that ...

Credit: Getty Images Psycho-oncology experts discussed strategies for managing the mental health burdens of cancer survivorship and supporting caregivers. Patients with cancer experience distress not ...

(HealthDay News) — Risk-based strategies are superior to the US Preventive Services Task Force (USPSTF) criteria for optimizing efficiency and minimizing variation of lung cancer screening across ...

(HealthDay News) — The US Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism ...